MAPT and concussion: One study evaluated a panel of blood-based biomarkers with and without neuroimaging findings (CT and MRI) and whether it discriminates between patients with suspected mTBI using single-molecule array technology.208 The panel included GFAP, tau, UCH-L1, and NfL.